semaglutide china Chinese companies turn to generics as shipments behind US weight-loss craze fade Novo Nordisk Cuts China Wegovy

The studies, which reviewed data from hundreds of thousands of patients in Denmark and Norway, build upon earlier findings from Harvard University

Pharmacology & Therapeutics , 27(1), 50- sixty-four

Prespecified patient subgroups, endpoints and key study limitations of the included trials are summarised in Table 1

The randomised, double-blind, placebo-controlled study enrolled 2,339 adults with obesity or overweight and at least one weight-related health condition (such as high blood pressure or heart disease) but without diabetes

The key here is to set your expectations before starting the process, just as you would for your potential outcomes if you were using Wegovy